Navigation Links
MAP Pharmaceuticals Acquires Proprietary Drug Particle Formulation Technology From Eiffel/Telesso Technologies Limited
Date:6/24/2008

MOUNTAIN VIEW, Calif., June 24 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that Telesso Technologies Limited, formerly Eiffel Technologies Limited ("Eiffel"), has agreed to transfer and assign to MAP Pharmaceuticals previously licensed intellectual property and know-how, as well as capital equipment, owned by Eiffel related to its supercritical fluid technology ("SCF").

MAP Pharmaceuticals will make payments to Eiffel upon the successful transfer of the intellectual property and related capital equipment. Eiffel will receive milestone payments upon achievement of certain late stage clinical and regulatory milestones for the first product developed by MAP Pharmaceuticals using the Eiffel technology. The new agreement supersedes the research and development agreement entered into by the companies in 2005 and eliminates all royalty and milestone commitments under the previous agreement.

Since 2005, MAP Pharmaceuticals and Eiffel have collaborated on the development of methods for manufacturing drug particles either alone, or as a combination of two drugs in a single particle, using Eiffel's SCF technology. The technology has been shown in clinical studies to be applicable to inhaled formulations of biologics and combination drug products. MAP Pharmaceuticals believes the technology may also apply to the combination of three different drugs into a single particle for inhalation or for use in other dosage forms.

"This acquisition allows MAP Pharmaceuticals to assume direct control of processing and manufacturing of drug formulations relating to the SCF technology, while also allowing full control of intellectual property," said Timothy S. Nelson, President and Chief Executive Officer
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... BUFFALO, N.Y. A novel compound that targets an ... host of cocaine addiction behaviors, including relapse behavior, a ... research provides strong evidence that this may be a ... no effective medications exist., The UB research was published ... last week. , In the study, the compound, RO5263397, ...
(Date:4/23/2014)... that can rapidly screen a large cell population ... that population has been seriously lacking," said Virginia ... Royal Society of Chemistry journal Chemical Science ... coworkers have developed a novel technique that detects ... Sci. , 2014, DOI: 10.1039/C4SC00578C, http://pubs.rsc.org/en/content/articlelanding/2014/sc/c4sc00578c#!divAbstract ). ...
(Date:4/23/2014)... as the United States, it may come as a surprise ... adequate food due to lack of money or other financial ... the University of Illinois using data from the National Health ... are dealing with hunger are also facing negative health and ... over age 60 faced the threat of hungerthat translates to ...
(Date:4/23/2014)... Occupational and Leisure Time Physical Activity on Mobility Limitation ... midlife increases the risk of mobility limitation in old ... is found in a study which followed up 5,200 ... conducted at the Gerontology Research Center in Finland and ... labor is often repetitive, wears the body and lasts ...
(Date:4/23/2014)... disease has been a rapidly evolving pursuit with ... crook in the research road, scientists have found ... associated with the disease. The report, which appears ... could have important implications for developing novel treatments. ... explain that for years, research has suggested a ...
Breaking Medicine News(10 mins):Health News:Novel compound halts cocaine addiction and relapse behaviors 2Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:More Americans in their golden years are going hungry 2Health News:Midlife occupational and leisure-time physical activity limits mobility in old age 2
... advanced colorectal cancer as intravenous treatment with a similar ... as those on standard chemotherapy, but the pill caused ... 5-fluorouracil (5-FU), the chemotherapy regimen most commonly used to ... to use and produces fewer side effects, and that's ...
... An experimental estrogen lotion appears to reduce the number of ... from a pivotal-stage trial of the drug Estrasorb. If approved ... therapy in lotion form.// ,The drug's developer Novavax ... lotion reduced by 80% the total number of hot flashes ...
... researchers are warning that blood transfusions can cause a ... to more than 50 deaths// nationwide since 1990. About ... patients receive transfusions each year. Testing for the antibodies ... routine screening of the nation's blood supply. ,The ...
... Women who gain 38 pounds or more while pregnant ... by 40%.,Excess pregnancy weight gain// doesn't increase breast cancer ... for post-menopausal women. ,The study found that ... raise their post-menopausal risk of developing breast cancer by ...
... Food and Drug Administration has approved a new treatment ... radiofrequency energy to// shrink small areas of the cornea, ... Unlike laser in situ keratomileusis (LASIK), in which the ... conductive keratoplasty does not require cutting or tissue removal. ...
... Drug Administration recommends pregnant women to avoid swordfish, shark, ... oysters, marlin, halibut, pike, walleye, white croaker, and largemouth ... and young children to eat only small amounts of ... Food and Drug Administration softened its warning to pregnant ...
Cached Medicine News:
(Date:1/15/2014)...  In an unprecedented effort to curb the spread of "superbugs" such ... vehicles, an advanced and portable UV germicidal lamp manufactured by MRSA-UV ... In order to prevent EMS paramedics and transport ... West Palm Beach Fire Rescue is the first in ...
(Date:1/15/2014)... R.I. , Jan. 15, 2014 MultiCell Technologies, ... filed a U.S. provisional patent application concerning composition of ... to achieve targeted tumor cell death.  ... small noncoding double stranded RNA molecules (VSRNAs) which interfere ...
(Date:1/15/2014)... , Jan. 15, 2014 The Cadence Fitness ... Fitness Center by the Medical Fitness Association, a non-profit ... achieve their full potential. The Cadence Fitness & Health ... western suburbs and second in the Chicagoland area. ...
Breaking Medicine Technology:Superbugs No Longer Ride In Rescue Vehicles 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
... China Nuvo Solar Energy, Inc. (OTCQB: CNUV) today ... Bluewater Surgical, Inc. to a western distributorship. Bluewater surgical ... medicine, trauma surgery and more to acute care hospitals ... the high priced medical device providers in the marketplace. ...
... 4, 2011 Scrip , a leading global ... philanthropic foundation, the Abbott Fund, with a 2011 ... Scrip,s seventh annual awards ceremony in London ... of the significant results achieved through a decade-long, public-private ...
Cached Medicine Technology:China Nuvo Solar Energy, Inc. Announces Third-Party Distribution Agreement With Bluewater Surgical, Inc. 2China Nuvo Solar Energy, Inc. Announces Third-Party Distribution Agreement With Bluewater Surgical, Inc. 3Abbott Honored With Scrip Award for Leadership in Corporate Social Responsibility 2Abbott Honored With Scrip Award for Leadership in Corporate Social Responsibility 3Abbott Honored With Scrip Award for Leadership in Corporate Social Responsibility 4
Stainless steel lockable wall display for up to 12 frames....
Omni labs carries an extensive line of frames, lenses, soft contacts, RGP lenses, and many other products and services. It supports Zeiss, American optical, Sola, Rodenstock, Zylowear, Eyewear design...
A compact showcase unit. Made with tempered glass, one, two or three adjustable shelves, a door with a safety lock. Equipped with fluorescent lighting and levelers. Display is available in various si...
Classic is proud to provide top-quality vision eyewear to physicians, health maintenance organizations (HMOs), and numerous state and federal government programs. Classic Laboratory produces over 150...
Medicine Products: